Impact of urgently initiated tele-prescription due to COVID-19 on glycemic control in patients with type 2 diabetes
Sung-Don Park, Na-young Kim, Jae-Han Jeon, Jung-Guk Kim, In-Kyu Lee, Keun-Gyu Park, Yeon-Kyung Choi
Korean J Intern Med. 2021;36(4):942-948. Published online 2021 Jun 7 DOI: https://doi.org/10.3904/kjim.2020.464
Citations to this article as recorded by 
Digital Health and Shared Decision-Making in Diabetes Care – A Survey Initiative in Patients and Clinicians
Faiza Mubeen, Cecilia C. Low Wang, Ahmad Al Maradni, Vijay Shivaswamy, Archana R. Sadhu
Endocrine Practice.2023; 29(7): 538. CrossRef
Telehealth use in patients with type 2 diabetes in Australian general practice during the COVID-19 pandemic: a retrospective cohort study
Chisato Imai, Judith Thomas, Rae-Anne Hardie, Christopher Pearce, Tony Badrick, Andrew Georgiou
BJGP Open.2022; 6(3): BJGPO.2021.0200. CrossRef
Quality outcome of diabetes care during COVID-19 pandemic: a primary care cohort study
Stefania Di Gangi, Benjamin Lüthi, Laura Diaz Hernandez, Andreas Zeller, Stefan Zechmann, Roland Fischer
Acta Diabetologica.2022; 59(9): 1189. CrossRef
Health Care Access and Use Among Adults with Diabetes During the COVID-19 Pandemic — United States, February–March 2021
Mark É. Czeisler, Catherine E. Barrett, Karen R. Siegel, Matthew D. Weaver, Charles A. Czeisler, Shantha M.W. Rajaratnam, Mark E. Howard, Kai McKeever Bullard
MMWR. Morbidity and Mortality Weekly Report.2021; 70(46): 1597. CrossRef